Navigation Links
Merck, ICMR to conduct joint trials on cervical cancer vaccine

Merck & Co, known as MSD India, has entered into a collaboration with the Indian Council of Medical Research (ICMR) to conduct studies on the former's investigational cervical cancer drug, Gardasil.//

This is the first public-private partnership in vaccine development in India. Under the agreement, clinical trials will be conducted for a human pappiloma virus (HPV) vaccine that causes cervical cancer.

The vaccine that has been developed by Merck and will be tried on 30 to 40,000 women in two phases. The volunteers will be between 17 and 18 years of age.

While the first phase will take two years, the second will take four years to complete and the cost of the trials is estimated to be around $45 million.

The Indian trials will be carried out to see if it's safe and equally efficacious for women in a tropical country.

Upon completion of the study in India, the two partners will work together to assess the efficacy of the vaccine in the Indian population and identifying ways of providing the same.

The New Jersey-headquartered pharma company has already applied for permission from the Food and Drug Administration (FDA) to launch the vaccine in the US market and is likely to apply for regulatory approval for the EU region soon.

This study is in addition to the Phase III clinical trials that have to be completed for any drug to be approved by the regulator. Dr Leonard Tauro, MD, MSD India says, "We want to know how the vaccine would respond to the Indian conditions."

The company will supply the vaccine free of cost for its use in the study. Gardasil is designed to protect against four types of human papillomavirus (HPV) - 6, 11, 16 and 18. Besides Merck, GSK too is working on a similar vaccine.

About 5.1 lakh cases of cervical cancer are reported every year the world over, with nearly 80 per cent occurring in developing countries. The World Health Organization terms cervical cancer the mo st common form of cancer in India with over 1.3 lakh cases reported each year and 74,000 women dying annually.

The clinical trials with Merck's HPV vaccine would test its role in controlling the spread of the disease in India. If found successful, it may open a feasible option for MSD to market the drug in other developing countries.

Merck says that collaborative partnerships between industry, NGOs and individual governments are critical in determining the best approach to the introduction of investigational medicines and vaccines in the public sector of low-income countries.

ICMR is one of the oldest medical research councils in the world. It started in 1911 as the Indian Research Fund Association (IRFA) and was renamed ICMR in 1950, soon after Independence, on the recommendations of the health survey and development committee, headed by Sir Joseph Bhore. It has a network of 26 research institutes and over 70 field stations in various parts of the country, and has an annual budget of Rs. 231 crore (Rs. 2310 million).


Related medicine news :

1. NBE to conduct test for medical students from abroad
2. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
3. India to maintain Public domain Registry database of clinical trials conducted in India.
4. New Sexual Misconduct Rule Against Doctors In The US
5. Diabetic check-up conducted in Chitradurga
6. Bird flu test conducted in dead pigeon found in Ethiopia
7. Nurse accused of breach of conduct and duty
8. APEC to conduct mock bird flu exercise
9. UK doctor Charged By GMC For Professional Misconduct
10. GP Found Guilty Of Misconduct
11. Mammoottys fan club to help conduct eye camps
Post Your Comments:

(Date:11/25/2015)... WASHINGTON, D.C. (PRWEB) , ... November 25, 2015 , ... ... driving fatalities on our nation’s roadways has dropped below 10,000 for the first time ... to 10,076 in 2013. , According to data released by the National Highway Traffic ...
(Date:11/25/2015)... ... November 25, 2015 , ... An ... is resulting in a way for homeless people to have a more dignified ... a new initiative whereby they are repurposing plastic bags into sleeping mats for ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... offering lower prices in an early celebration of the early holiday shopping season. ... of $29.95 each (normally $33.95 ea). Black Friday promotional pricing is in addition ...
(Date:11/24/2015)... ... November 24, 2015 , ... Young patients with a ... Dr. Angela Wolfman and Dr. Kedar S. Lele, who are pediatric dentists in ... and fillings, the WaterLase iPlus 2.0™ system causes minimal discomfort and bleeding to the ...
(Date:11/24/2015)... ... 24, 2015 , ... DMG Productions announced that they will feature Aphria, Inc., ... via Discovery Channel. Dates and show times TBA. , Aphria, Inc., is a publicly ... of producing and supplying medical marijuana pursuant to the Marijuana for Medical Purposes Regulations ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 2015  DILON Diagnostics and GE Healthcare are pleased ... DILON to distribute GE,s Discovery NM750b Molecular Breast Imaging ... this distribution agreement will provide Dilon,s experienced distribution network ... and is considered an initial step in an ongoing ... clinicians and their patients. --> ...
(Date:11/24/2015)... November 24, 2015 Sectra (STO: ... has entered into a multi-year agreement to deploy ... investment will provide the Breast Center a future-proof platform ... (STO: SECT B) announces that Breast Center of ... deploy Breast Imaging PACS in its two freestanding imaging ...
(Date:11/24/2015)... FRAMINGHAM, Mass. , Nov. 24, 2015   ... leading innovator of less-invasive, miniaturized circulatory support technologies that ... announced that President and Chief Executive Officer Doug ... Jaffray 27 th Annual Healthcare Conference on December ... being held December 1-2 in New York ...
Breaking Medicine Technology: